STUDIES ON THE MECHANISM OF CADMIUM-INDUCED INHIBITION OF THE HEPATIC MICROSOMAL MONO-OXYGENASE OF THE MALE-RAT

被引:67
作者
MEANS, JR [1 ]
CARLSON, GP [1 ]
SCHNELL, RC [1 ]
机构
[1] PURDUE UNIV,SCH PHARM & PHARMACAL SCI,DEPT PHARMACOL & TOXICOL,W LAFAYETTE,IN 47907
关键词
D O I
10.1016/0041-008X(79)90036-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cadmium is a potent inhibitor of hepatic drug metabolism but little is known about the biochemical mechanisms involved. Male rats receiving a single dose of cadmium acetate (2.0 mg Cd2+/kg, ip) exhibited significant decreases in hepatic microsomal metabolism of hexobarbital (79%), ethylmorphine (71%), and aniline (47%), as well as decreased amounts of both microsomal cytochrome P-450 (39%) and cytochrome b5 (30%) 72 hr after administration of the metal. In addition, the magnitudes of microsomal hexobarbital, ethylmorphine, and aniline binding spectra were significantly reduced. NADPH-cytochrome c reductase activity was not altered. In vitro addition of Cd2+ (10-6 to 10-3 m) to liver microsomes produced a concentration-dependent inhibition of the metabolism of the substrates tested, a reduction in the level of cytochrome P-450 which was accompanied by an increase in the level of the inactive form of the hemo-protein, P-420, and decreases in the microsomal binding spectra of the three substrates. In kinetic studies, apparent Vmax values were significantly lowered for ethylmorphine N-demethylase (75%) and aniline hydroxylase (57%) by cadmium treatment. The apparent Km value for aniline hydroxylase was not altered, but that for ethylmorphine N-demethylase was significantly decreased following cadmium treatment. After in vitro cadmium addition, concentration-dependent decreases were observed in the apparent Vmax and Km values for both microsomal reactions. © 1979.
引用
收藏
页码:293 / 304
页数:12
相关论文
共 36 条
[1]   LEAD AND METHYL MERCURY - EFFECTS OF ACUTE EXPOSURE ON CYTOCHROME-P-450 AND MIXED FUNCTION OXIDASE SYSTEM IN LIVER [J].
ALVARES, AP ;
LEIGH, S ;
KAPPAS, A ;
COHN, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 135 (06) :1406-&
[2]  
ALVARES AP, 1974, DRUG METAB DISPOS, V2, P259
[3]  
ANDERS MW, 1966, MOL PHARMACOL, V2, P319
[4]  
Anderson VL, 2018, DESIGN EXPT REALISTI
[5]  
BAYER E, 1969, CHEM COMMUN, P109
[6]  
BRODIE BB, 1953, J PHARMACOL EXP THER, V109, P26
[7]   NUCLEAR CA-115 - UPTAKE AND DISAPPEARANCE CORRELATED WITH CADMIUM-BINDING PROTEIN-SYNTHESIS [J].
BRYAN, SE ;
HIDALGO, HA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1976, 68 (03) :858-866
[8]  
COMAI K, 1973, J BIOL CHEM, V248, P4947
[9]  
DALLNER G, 1963, ACTA PATHOL MICROB S, V166, P7
[10]  
DRAPER N, 1966, APPLIED REGRESSION A